Takeda Pharmaceutical Company Limited
PEPTIDE COMPOUND

Last updated:

Abstract:

The present invention provides a novel peptide compound having an activating action on GIP receptors and use of the peptide compound as a medicament. Specifically, a peptide containing a sequence represented by the formula (I) or a salt thereof and a medicament comprising the same are provided. P.sup.1-Tyr-A2-Glu-Gly-Thr-A6-A7-A8-A9-A10-A11-A12-A13-A14-A15-A16-A17-A- 18-A19-A20-A21-A22-A23-A24-A25-A26-A27-A28-A29-A30-A31-A32-A33-A34-A35-A36- -A37-A38-A39-A40-P.sup.2 (I) wherein each symbol is as defined herein.

Status:
Application
Type:

Utility

Filling date:

29 Aug 2019

Issue date:

7 May 2020